X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

SNPX

Closed

Synaptogenix Inc

8.35
+0.50 (+6.37%)
Last Update: 01 Jul 2025 16:30:00
Yesterday: 7.85
Day's Range: 6.1 - 8.61
Send
When Written:
 
0.849
Synaptogenix Inc is a biopharmaceutical company that focuses on developing novel therapies for Alzheimer's disease and other neurodegenerative disorders. The company's lead drug candidate, NX-1207, is a novel therapeutic protein that is being developed for the treatment of Alzheimer's disease. NX-1207 is designed to target beta-amyloid, a protein that is believed to play a key role in the development of Alzheimer's disease. The company is also working on developing other drug candidates that target different aspects of the disease, including neuroinflammation and oxidative stress. Synaptogenix Inc is headquartered in New York, USA, and was founded in 2002.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X